Methylene blue treatment in experimental ischemic stroke: A mini-review
Stroke is among the leading causes of death and long-term disability. Methylene blue (MB), a drug grandfathered by the Food and Drug Administration with a long history of safe usage in humans for treating methemoglobinemia and cyanide poisoning, has recently been shown to be neuroprotective in neuro...
Gorde:
| Egile Nagusiak: | , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Wolters Kluwer Medknow Publications
2016-01-01
|
| Saila: | Brain Circulation |
| Gaiak: | |
| Sarrera elektronikoa: | http://www.braincirculation.org/article.asp?issn=2394-8108;year=2016;volume=2;issue=1;spage=48;epage=53;aulast=Jiang |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|